|
1
|
Wang B, He M and Wang L, Engelgau MM, Zhao
W and Wang L: Breast cancer screening among adult women in China,
2010. Prev Chronic Dis. 10:E1832013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
MacDonald V: Chemotherapy: managing side
effects and safe handling. Can Vet J. 50:665–668. 2009.PubMed/NCBI
|
|
3
|
Lin X, Gao R, Zhang Y, Qi N, Zhang Y,
Zhang K, He H and Tang X: Lipid nanoparticles for chemotherapeutic
applications: strategies to improve anticancer efficacy. Expert
Opin Drug Deliv. 9:767–781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Jong WH and Borm PJ: Drug delivery and
nanoparticles: applications and hazards. Int J Nanomed. 3:133–149.
2008. View
Article : Google Scholar
|
|
5
|
Shohdy KS and Alfaar AS: Nanoparticles
targeting mechanisms in cancer therapy: current limitations and
emerging solutions. Ther Deliv. 4:1197–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bastakoti BP, Torad NL and Yamauchi Y:
Polymeric micelle assembly for the direct synthesis of
platinum-decorated mesoporous TiO2 toward highly
selective sensing of acetaldehyde. ACS Appl Mater Interfaces.
6:854–860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quan L, Zhang Y, Crielaard BJ, Dusad A,
Lele SM, Rijcken CJ, Metselaar JM, Kostková H, Etrych T, Ulbrich K,
et al: Nano-medicines for inflammatory arthritis: head-to-head
comparison of glucocorticoid-containing polymers, micelles, and
liposomes. ACS Nano. 8:458–466. 2014. View Article : Google Scholar :
|
|
8
|
Chang DK, Li PC, Lu RM, Jane WN and Wu HC:
Peptide-mediated liposomal doxorubicin enhances drug delivery
efficiency and therapeutic efficacy in animal models. PLoS One.
8:e832392013. View Article : Google Scholar
|
|
9
|
Wang Q, Zhuang X, Mu J, Deng ZB, Jiang H,
Zhang L, Xiang X, Wang B, Yan J, Miller D, et al: Delivery of
therapeutic agents by nanoparticles made of grapefruit-derived
lipids. Nat Commun. 4:18672013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park K: Lessons learned from
thermosensitive liposomes for improved chemotherapy. J Control
Release. 174:2192014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sabnis N and Lacko AG: Drug delivery via
lipoprotein-based carriers: answering the challenges in systemic
therapeutics. Ther Deliv. 3:599–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lacko AG, Nair M, Prokai L and McConathy
WJ: Prospects and challenges of the development of
lipoprotein-based formulations for anti-cancer drugs. Expert Opin
Drug Deliv. 4:665–675. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lassalle HP, Marchal S, Guillemin F,
Reinhard A and Bezdetnaya L: Aptamers as remarkable diagnostic and
therapeutic agents in cancer treatment. Curr Drug Metab.
13:1130–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bunka DH, Platonova O and Stockley PG:
Development of aptamer therapeutics. Curr Opin Pharmacol.
10:557–562. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi H, Cui W, He X, Guo Q, Wang K, Ye X
and Tang J: Whole cell-SELEX aptamers for highly specific
fluorescence molecular imaging of carcinomas in vivo. PLoS One.
8:e704762013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meyer S, Maufort JP, Nie J, Stewart R,
McIntosh BE, Conti LR, Ahmad KM, Soh HT and Thomson JA: Development
of an efficient targeted cell-SELEX procedure for DNA aptamer
reagents. PLoS One. 8:e717982013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dassie JP and Giangrande PH: Current
progress on aptamer-targeted oligonucleotide therapeutics. Ther
Deliv. 4:1527–1546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Subramanian N, Raghunathan V, Kanwar JR,
Kanwar RK, Elchuri SV, Khetan V and Krishnakumar S: Target-specific
delivery of doxorubicin to retinoblastoma using epithelial cell
adhesion molecule aptamer. Mol Vis. 18:2783–2795. 2012.PubMed/NCBI
|
|
19
|
Tacar O, Sriamornsak P and Dass CR:
Doxorubicin: an update on anticancer molecular action, toxicity and
novel drug delivery systems. J Pharm Pharmacol. 65:157–170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carvalho C, Santos RX, Cardoso S, Correia
S, Oliveira PJ, Santos MS and Moreira PI: Doxorubicin: the good,
the bad and the ugly effect. Curr Med Chem. 16:3267–3285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Speelmans G, Staffhorst RW, De Kruijff B
and De Wolf FA: Transport studies of doxorubicin in model membranes
indicate a difference in passive diffusion across and binding at
the outer and inner leaflets of the plasma membrane. Biochemistry.
33:13761–13768. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kamba SA, Ismail M, Hussein-Al-Ali SH,
Ibrahim TA and Zakaria ZA: In vitro delivery and controlled release
of doxorubicin for targeting osteosarcoma bone cancer. Molecules.
18:10580–10598. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaikh IM, Tan KB, Chaudhury A, Liu Y, Tan
BJ, Tan BM and Chiu GN: Liposome co-encapsulation of synergistic
combination of irinotecan and doxorubicin for the treatment of
intraperitoneally grown ovarian tumor xenograft. J Control Release.
172:852–861. 2013. View Article : Google Scholar
|
|
24
|
Zhaorigetu S, Rodriguez-Aguayo C, Sood AK,
Lopez-Berestein G and Walton BL: Delivery of negatively charged
liposomes into the atherosclerotic plaque of apolipoprotein
E-deficient mouse aortic tissue. J Liposome Res. 24:182–190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alavi SE, Esfahani MK, Alavi F, Movahedi F
and Akbarzadeh A: Drug delivery of hydroxyurea to breast cancer
using liposomes. Indian J Clin Biochem. 28:299–302. 2013.
View Article : Google Scholar :
|
|
26
|
Remaut K, Lucas B, Braeckmans K, Sanders
NN, Demeester J and De Smedt SC: Delivery of phosphodiester
oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Biochemistry. 45:1755–1764. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ciani L, Casini A, Gabbiani C, Ristori S,
Messori L and Martini G: DOTAP/DOPE and DC- Chol/DOPE lipoplexes
for gene delivery studied by circular dichroism and other
biophysical techniques. Biophys Chem. 127:213–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
